Reuters logo
BRIEF-CytoSorbents receives additional $5 mln in non-dilutive debt financing from Bridge Bank
2017年7月5日 / 上午11点26分 / 5 个月前

BRIEF-CytoSorbents receives additional $5 mln in non-dilutive debt financing from Bridge Bank

July 5 (Reuters) - CytoSorbents Corp

* CytoSorbents receives additional $5 million in non-dilutive debt financing from Bridge Bank

* CytoSorbents Corp - on June 30, received an additional $5 million from Life Sciences Group of Bridge Bank

* CytoSorbents Corp - intends to use proceeds from loan to provide working capital to fund ongoing operations and to support clinical trials

* CytoSorbents -On June 30, elected to drawdown extra $5 million of funding available under loan, security agreement, bringing total borrowings under facility to $10 million

* CytoSorbents - as result of additional drawdown, period of interest-only payments on both term loans is extended by six months through Dec. 31 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below